Zhejiang Gongdong Medical Technology Management

Management criteria checks 4/4

Zhejiang Gongdong Medical Technology's CEO is Weifeng Zhong, appointed in Oct 2017, has a tenure of 6.58 years. directly owns 0.77% of the company’s shares, worth CN¥43.74M. The average tenure of the management team and the board of directors is 6.6 years and 6.6 years respectively.

Key information

Weifeng Zhong

Chief executive officer

CN¥541.4k

Total compensation

CEO salary percentage	n/a
CEO tenure	6.6yrs
CEO ownership	0.8%
Management average tenure	6.6yrs
Board average tenure	6.6yrs

Recent management updates

Recent updates

Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Mar 28

Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Mar 06

Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Feb 27

CEO

Weifeng Zhong (46 yo)

6.6yrs

Tenure

CN¥541,400

Compensation

Mr. Weifeng Zhong has been General Manager and Director of Zhejiang Gongdong Medical Technology Co.,Ltd. since October 2017.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Weifeng Zhong	GM & Director	6.6yrs	CN¥541.40k	0.77% CN¥ 43.7m
Jianwei Pan	Deputy GM & Director	6.6yrs	CN¥370.50k	no data
Shiwei Jin	Board Secretary & Director	6.6yrs	CN¥443.90k	0.016% CN¥ 909.9k
Yuan Gao	Deputy General Manager	6.6yrs	CN¥443.80k	0.012% CN¥ 682.7k

6.6yrs

Average Tenure

50.5yo

Average Age

Experienced Management: 605369's management team is seasoned and experienced (6.6 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Weifeng Zhong	GM & Director	6.6yrs	CN¥541.40k	0.77% CN¥ 43.7m
Jianwei Pan	Deputy GM & Director	6.6yrs	CN¥370.50k	no data
Shiwei Jin	Board Secretary & Director	6.6yrs	CN¥443.90k	0.016% CN¥ 909.9k
Huiyong Shi	Chairman	6.6yrs	CN¥635.90k	66.39% CN¥ 3.8b
Jingxiang Zhang	Chairman of the Supervisory Board	6.6yrs	no data	no data
Sengui Zeng	Employee Representative Supervisor	6.6yrs	no data	no data
Guijun Shen	Supervisor	6.6yrs	no data	no data

6.6yrs

Average Tenure

46yo

Average Age

Experienced Board: 605369's board of directors are considered experienced (6.6 years average tenure).

Zhejiang Gongdong Medical Technology Management

Management criteria checks 4/4

Key information

Recent management updates

Zhejiang Gongdong Medical Technology Co., Ltd., Annual General Meeting, May 28, 2024

Zhejiang Gongdong Medical Technology Co., Ltd., Annual General Meeting, May 28, 2024

No independent directors

Recent updates

Zhejiang Gongdong Medical Technology Co., Ltd., Annual General Meeting, May 28, 2024

Zhejiang Gongdong Medical Technology Co., Ltd., Annual General Meeting, May 28, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Now 21% overvalued after recent price rise

Now 21% overvalued

Zhejiang Gongdong Medical Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Estimating The Intrinsic Value Of Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369)

Now 21% overvalued

Zhejiang Gongdong Medical Technology Co., Ltd. (SHSE:605369) Looks Just Right With A 27% Price Jump

Zhejiang Gongdong Medical Technology (SHSE:605369) Is Reinvesting At Lower Rates Of Return

Investor sentiment deteriorates as stock falls 21%

Now 20% overvalued

Zhejiang Gongdong Medical Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024

Third quarter 2023 earnings released: EPS: CN¥0.25 (vs CN¥0.88 in 3Q 2022)

New minor risk - Profit margin trend

First quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.84 in 1Q 2022)

Investor sentiment deteriorates as stock falls 17%

Investor sentiment deteriorates as stock falls 19%

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

No independent directors

Now 20% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: CN¥0.88 (vs CN¥0.67 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: EPS: CN¥1.03 (vs CN¥0.87 in 2Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥1.07 (vs CN¥0.83 in 3Q 2020)

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.87 (vs CN¥0.78 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.99 (vs CN¥0.53 in 1Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥3.48 (vs CN¥1.89 in FY 2019)

Zhejiang Gongdong Medical Technology Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 08, 2021

Investor sentiment deteriorated over the past week

New 90-day low: CN¥59.19

Third quarter earnings released

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age